← All trials
NCT00587041
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2006
- Primary completion
- Jul 1, 2009
- Completion date
- Jul 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 40
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Mayo ClinicLead sponsor
- Mayo ClinicOverall official - principal investigator
- National Center for Complementary and Integrative Health (NCCIH)Collaborator
- National Center for Research Resources (NCRR)Collaborator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Collaborator
- Mayo ClinicReponsible party - principal investigator
- National Institutes of Health (NIH)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.